Head-to-head · Cost-Efficiency Index
AbundRX vs Bon Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
AbundRX
Cost-first shoppers, with the caveat that the advertised price's time period is unconfirmed.
Visit AbundRXBon Health
Cost-first shoppers who want transparent, no-membership GLP-1 with physician-titrated dosing.
Visit Bon HealthThe verdict
AbundRX and Bon Health tie on the Cost-Efficiency Index at 65/100, so neither wins outright on the numbers. For most shoppers we'd start with AbundRX (ranked #157, a hair above #158) — Cost-first shoppers, with the caveat that the advertised price's time period is unconfirmed. But Bon Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs AbundRX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | AbundRX | Bon Health |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 65/100 |
| Semaglutide / mo | $99/mo (starting dose, compounded) | $120/mo (12-month plan, compounded) |
| Tirzepatide / mo | $149/mo (starting dose, compounded) | $170/mo (12-month plan, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $1,440 |
| Tirzepatide / yr (modeled) | $1,788 | $2,040 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #157 | #158 |
AbundRX
65/100Where the value is
- LegitScript certification badge confirmed present on the live homepage
- Simple, fast online health assessment with two clear compounded GLP-1 pathways
- Genuinely low advertised entry price ($99 semaglutide / $149 tirzepatide) as verified directly from the site's own product cards — cheaper than the figure currently on file
The tradeoffs
- The site does not state whether '$99'/'$149' is a monthly, one-time, or first-order price — no duration label appears anywhere near either figure
- No dose amount or supply quantity is disclosed for either price
Bon Health
65/100Where the value is
- Transparent commitment-tier pricing from $170/mo (annual) for compounded semaglutide and tirzepatide; $0 membership fee, cancel anytime
- Physician-led: comprehensive medical review and physician-titrated dosing, not a 2-minute quiz
- 24/7 physician support included free with your order; 1-3 day rapid dispatch
The tradeoffs
- The advertised rates need a full year paid up front; billed monthly, semaglutide is $230 and the annual figure nearly doubles
- The brand-name pages are marketing, not products — every Wegovy, Ozempic, Zepbound and Mounjaro CTA reads 'Coming Soon' and points back to the compounded version
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.